(MENAFN- EIN Presswire) EINPresswire/ -- The global Abierixin Market is projected to expand from USD 101.0 million in 2025 to USD 179.5 million by 2035, representing an absolute growth of USD 78.5 million and nearly 193% market expansion over the decade. This translates into a steady 5.9% CAGR, driven by rising demand for natural antioxidants across nutraceuticals, functional foods, aquaculture feed, pharmaceuticals, and premium cosmetics.

Explore trends before investing – request a sample report today!

Microalgae Leads Industry Transformation

Microalgae-based Abierixin contributes over 40% of the market in 2025, dominating due to its clean-label appeal, high bioavailability, and sustainable production. Encapsulation advancements enhance stability and targeted delivery, cementing microalgae's leadership across supplements, functional foods, and cosmetic formulations.

Market Growth Phases

.2025–2030: Market grows to USD 135.7 million, driven by dietary supplements, fortified foods, and aquaculture feed. Microalgae dominates production due to scalability and regulatory approvals.
.2030–2035: Accelerated growth to USD 179.5 million is fueled by pharmaceutical applications, anti-aging cosmetics, AI-driven fermentation, and encapsulation technology. Dietary supplements and food & beverages together capture over 65% market share by 2035.

Key Market Drivers

.Preventive Healthcare: Rising consumer preference for natural antioxidants supporting eye health, cardiovascular function, and immunity.
.Aquaculture & Feed Enrichment: Demand in fish and shrimp pigmentation and immunity drives adoption, particularly in Japan, South Korea, and Nordic regions
.High Production Costs: Capital-intensive microalgae cultivation and fermentation limit adoption in price-sensitive markets.
.Formulation Complexity: Sensitivity to oxidation, light, and heat necessitates encapsulation, adding to production costs.

Trends
.Advanced encapsulation and controlled-release delivery systems improving absorption and stability.
.Shift toward regionalized, sustainable production aligned with EU Green Deal and zero-waste initiatives in Asia.

Segment Insights

.Form: Encapsulated/microencapsulated Abierixin dominates with 25% share, fastest CAGR at 8.5%.
.Application: Dietary supplements & nutraceuticals lead with 30% share, reflecting preventive health trends.
.Source: Microalgae is the leading supply origin, offering high antioxidant content and eco-friendly cultivation.

Regional Outlook

Asia-Pacific is the fastest-growing market, led by China (4.7% CAGR) and India (3.6% CAGR), driven by functional foods, aquaculture, and cosmetics. Europe maintains steady growth with strong nutraceutical compliance and R&D investments. North America shows moderate expansion, focusing on formulation-driven innovations and encapsulated products.

Stay ahead with quarterly and annual data updates.

Competitive Landscape

The market features a mix of global leaders, mid-sized innovators, and regional specialists. DSM-Firmenich, BASF SE, Kemin Industries, Algatech, Cyanotech Corporation, Fuji Chemical Industries are key players driving encapsulation innovation, AI-optimized fermentation, and sustainable algae cultivation. Competitive strategies increasingly emphasize integrated service models, combining ingredient supply with co-development partnerships.

Key Developments:

.Jan 2025: DSM-Firmenich expands Swiss algae production facility, focusing on EFSA-compliant encapsulated nutraceuticals.
.Feb 2025: BASF SE launches pharma-grade Abierixin beadlets for cardiovascular and ophthalmic applications in Germany.

Why FMI:

About Future Market Insights (FMI)

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 companies and global enterprises. Operating in the U.S., UK, India, and Dubai, FMI provides strategic, data-backed insights across 30+ industries and 1,200 markets worldwide.

MENAFN24112025003118003196ID1110388024